Repare Therapeutics Inc expected to post a loss of 89 cents a share - Earnings Preview

Repare Therapeutics

04/11/2022 17:15

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on November 8
(estimated). 
    * The St-laurent Quebec-based  company is expected to report
 a
468.3% increase in revenue to $1.58 million from $278 thousand a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Repare Therapeutics
Inc
is for a loss of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $29.5​, above​ its last closing price
of $14.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.84       -0.85      -0.91     Missed  -7.5
 Mar. 31 2022  -0.86       -0.86      -0.83     Beat    3
 Dec. 31 2021  -0.74       -0.74      -0.70     Beat    5.4​
 Sep. 30 2021  -0.71       -0.71      -0.83     Missed  -16.9
 ​​Jun.        -0.60       -0.60      -0.71     Missed  -17.4
 30 2021                                                
 Mar. 31 2021  -0.51       -0.51      -0.58     Missed  -14.6​
 Dec. 31 2020  -0.40       -0.39      -0.41     Missed  -3.8
 Sep. 30 2020  -0.39       -0.38      -0.37     Beat    2.2
 This summary was machine generated November 4 at 17:15 GMT.  All
figures in US dollars  unless otherwise stated